4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-022114
Chief Technical Officer sold 554 shares at $26.87 ($14,886)
- Chief Technical Officer acquired 1,563 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/tm236871-10_4seq1.xml…